Apolipoprotein C subtype distribution in type 2 diabetes mellitus

Area of Science:

• Biochemistry
• Endocrinology
• Metabolic Disorders

Background:

• Type 2 diabetes mellitus (T2DM) is frequently associated with dyslipidemia.
• Understanding the specific lipid and apolipoprotein alterations in T2DM is crucial for risk stratification and management.

Purpose of the Study:

• To investigate plasma lipid levels and Very Low-Density Lipoprotein (VLDL) apolipoprotein C (apo C) composition in Type 2 diabetic patients.
• To compare these parameters between normolipidemic and hyperlipidemic diabetic patients and matched controls.

Main Methods:

• Blood samples were collected from Type 2 diabetic patients at initial clinic visit before treatment.
• Patients were categorized into normolipidemic and hyperlipidemic groups.
• Lipid profiles and VLDL apo C isoform distribution were analyzed and compared with control groups.

Main Results:

• Normolipidemic diabetic patients showed higher serum triglycerides, VLDL cholesterol, and lower HDL cholesterol compared to normolipidemic controls.
• Hyperlipidemic non-diabetic individuals had altered apo C II and apo C III-1 percentages versus normolipidemic controls.
• The relative distribution of apo C III isoforms and apo C II was comparable between normolipidemic and hyperlipidemic diabetic patients.

Conclusions:

• Type 2 diabetes is characterized by specific dyslipidemia patterns independent of overall lipid status.
• Apolipoprotein C composition within VLDL does not significantly differ between normo- and hyperlipidemic diabetic individuals, suggesting distinct pathophysiological mechanisms.